• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.

作者信息

Marakasova Ekaterina, Baranova Ancha

机构信息

School of Systems Biology, George Mason University (GMU), Fairfax, Virginia, USA.

School of Systems Biology, George Mason University (GMU), Fairfax, Virginia, USA

出版信息

mBio. 2021 Feb 2;12(1):e03447-20. doi: 10.1128/mBio.03447-20.

DOI:10.1128/mBio.03447-20
PMID:33531391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7858076/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b577/7858076/5300691a319d/mBio.03447-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b577/7858076/5300691a319d/mBio.03447-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b577/7858076/5300691a319d/mBio.03447-20-f0001.jpg

相似文献

1
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.麻腮风疫苗与新冠病毒：麻疹蛋白同源性可能导致交叉反应或补体激活保护作用。
mBio. 2021 Feb 2;12(1):e03447-20. doi: 10.1128/mBio.03447-20.
2
Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection".对马拉卡索娃和巴拉诺娃的回复，“MMR疫苗与COVID-19：麻疹蛋白同源性可能导致交叉反应或补体激活保护”
mBio. 2021 Feb 2;12(1):e03682-20. doi: 10.1128/mBio.03682-20.
3
Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.医护人员近期接种 MMR 疫苗与新冠病毒（Covid-19）：一项基于阴性对照的病例对照研究。
Vaccine. 2021 Jul 22;39(32):4414-4418. doi: 10.1016/j.vaccine.2021.06.045. Epub 2021 Jun 22.
4
Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease?麻疹-腮腺炎-风疹（MMR）抗体是新冠疾病的朋友还是敌人？
Arch Immunol Ther Exp (Warsz). 2023 Jun 21;71(1):15. doi: 10.1007/s00005-023-00680-1.
5
COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines.新型冠状病毒肺炎、季节性流感和麻疹：潜在的三重负担以及流感疫苗和麻疹、腮腺炎、风疹联合疫苗的作用
J R Soc Med. 2020 Dec;113(12):485-486. doi: 10.1177/0141076820972668. Epub 2020 Nov 11.
6
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course.36例接种腮腺炎-麻疹-风疹疫苗进行预防性接种的新冠病毒疾病病例：病程均为轻症。
Allergy. 2021 Mar;76(3):910-914. doi: 10.1111/all.14584. Epub 2020 Sep 29.
7
Measles-Mumps-Rubella Vaccine and COVID-19 Relationship.麻疹-腮腺炎-风疹疫苗与新冠病毒病的关系
mBio. 2020 Sep 22;11(5):e01832-20. doi: 10.1128/mBio.01832-20.
8
Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.麻疹、腮腺炎、风疹疫苗（普瑞希；葛兰素史克 - MMR）：关于其在预防麻疹、腮腺炎和风疹方面应用的综述
Drugs. 2003;63(19):2107-26. doi: 10.2165/00003495-200363190-00012.
9
Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.开放性随机试验：比较一种新型麻疹-腮腺炎-风疹疫苗与一种已获许可疫苗在12至24月龄儿童中的免疫原性和安全性。
Pediatr Infect Dis J. 2005 Dec;24(12):1083-8. doi: 10.1097/01.inf.0000183746.92218.f9.
10
Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial.两种不同效价麻疹-腮腺炎-风疹联合减毒活疫苗在 12-15 月龄健康儿童中接种的免疫原性和安全性：一项 III 期、随机、非劣效性试验。
Vaccine. 2018 Sep 11;36(38):5781-5788. doi: 10.1016/j.vaccine.2018.07.076. Epub 2018 Aug 10.

引用本文的文献

1
Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers.医护人员中麻疹、腮腺炎、风疹疫苗对严重急性呼吸综合征冠状病毒2的有效性和免疫原性
Viruses. 2025 Feb 1;17(2):215. doi: 10.3390/v17020215.
2
Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease?麻疹-腮腺炎-风疹（MMR）抗体是新冠疾病的朋友还是敌人？
Arch Immunol Ther Exp (Warsz). 2023 Jun 21;71(1):15. doi: 10.1007/s00005-023-00680-1.
3
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。

本文引用的文献

1
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.导致免疫球蛋白和补体消耗的失调细胞通路与 COVID-19 患者的严重程度相关。
Eur J Immunol. 2021 Mar;51(3):634-647. doi: 10.1002/eji.202048858. Epub 2021 Jan 22.
2
The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.补体系统凝集素途径在 SARS-CoV-2 肺损伤中的作用。
Transl Res. 2021 May;231:55-63. doi: 10.1016/j.trsl.2020.11.008. Epub 2020 Nov 20.
3
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
4
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals.慢性疾病患者与健康的 COVID-19 初筛阴性个体针对 SARS-CoV-2 刺突蛋白的交叉反应性抗体应答存在差异。
Sci Rep. 2022 Oct 7;12(1):16817. doi: 10.1038/s41598-022-20849-6.
5
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.一种高效的基于活减腮腺炎病毒的 SARS-CoV-2 疫苗候选物，表达六脯氨酸稳定的预融合刺突。
Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2201616119. doi: 10.1073/pnas.2201616119. Epub 2022 Jul 27.
6
Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming Hypothesis.抗乙型肝炎病毒抗体对新型冠状病毒肺炎重症病例的假定保护作用：一项证实假设的临床研究
Front Med (Lausanne). 2022 Jul 8;9:909660. doi: 10.3389/fmed.2022.909660. eCollection 2022.
7
Revisiting the potential role of BCG and MMR vaccines in COVID-19.重新探讨卡介苗和麻疹风疹联合疫苗在 COVID-19 中的潜在作用。
Sci Prog. 2022 Apr-Jun;105(2):368504221105172. doi: 10.1177/00368504221105172.
8
Does the rubella immunoglobulin G affect the severity of COVID- 19?  : Rubella immunoglobulin G and COVID- 19.风疹 IgG 对 COVID-19 的严重程度有影响吗？：风疹 IgG 与 COVID-19。
BMC Microbiol. 2022 Jun 11;22(1):156. doi: 10.1186/s12866-022-02563-5.
9
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella.一种基于已获批准的麻疹、腮腺炎和风疹疫苗的新型黑色素瘤癌症疫苗。
Mol Ther Oncolytics. 2022 Apr 19;25:137-145. doi: 10.1016/j.omto.2022.04.002. eCollection 2022 Jun 16.
10
COVID-19 susceptibility and vaccination coverage for measles, rubella and mumps in students and healthcare workers in Trieste hospitals (NE Italy).的里雅斯特医院（意大利东北部）学生和医护人员中新冠病毒易感性以及麻疹、风疹和腮腺炎疫苗接种覆盖率
Vaccine X. 2022 Feb 25;10:100147. doi: 10.1016/j.jvacx.2022.100147. eCollection 2022 Apr.
分析新冠肺炎康复患者的麻疹-腮腺炎-风疹（MMR）滴度。
mBio. 2020 Nov 20;11(6):e02628-20. doi: 10.1128/mBio.02628-20.
4
and studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis.并且研究表明补体系统在新冠病毒致病过程中驱动凝血级联反应。
Comput Struct Biotechnol J. 2020;18:3734-3744. doi: 10.1016/j.csbj.2020.11.005. Epub 2020 Nov 11.
5
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.从头设计皮摩尔级 SARS-CoV-2 小蛋白抑制剂。
Science. 2020 Oct 23;370(6515):426-431. doi: 10.1126/science.abd9909. Epub 2020 Sep 9.
6
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
7
Is BCG vaccination causally related to reduced COVID-19 mortality?BCG 疫苗接种是否与降低 COVID-19 死亡率有因果关系？
EMBO Mol Med. 2020 Jun 8;12(6):e12661. doi: 10.15252/emmm.202012661. Epub 2020 May 26.
8
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
9
The EMBL-EBI search and sequence analysis tools APIs in 2019.2019 年的 EMBL-EBI 搜索和序列分析工具 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641. doi: 10.1093/nar/gkz268.
10
Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.麻疹病毒融合蛋白前融合构象复合物的结构与抑制剂。
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2496-2501. doi: 10.1073/pnas.1718957115. Epub 2018 Feb 20.